We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PAX:NASDAQPatria Investments Limited Analysis

Data as of 2026-05-28 - not real-time

$11.54

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Patria Investments (PAX) is trading at $11.54, comfortably above its recent support of $10.72 but still below the 20‑day SMA of $11.79 and the 50‑day SMA of $12.14, indicating a bearish price bias. The RSI sits near 45, suggesting neutral momentum, while the MACD line has just nudged above its signal, offering a faint bullish hint that could spark a short‑term bounce. Volume has been on a decreasing trend, reinforcing the downside pressure, and the 30‑day volatility is elevated at over 37%, reflecting a choppy trading environment. On the fundamentals side, revenue grew 22% year‑over‑year to $399 M with strong gross (58%) and operating (26%) margins, yet the current PE of 21.8 sits well above the industry average of 16.5, pointing to a valuation premium. Forward‑looking metrics are more encouraging: a forward PE of 7.4 and an upside potential of roughly 35% based on analyst targets suggest the stock may be undervalued relative to its earnings trajectory. The dividend yield is attractive at 5.34%, but the payout ratio exceeds 110%, raising concerns about sustainability. Investor sentiment is extremely bullish, as reflected by a Fear & Greed Index of 93 (Extreme Greed), which may be inflating the price despite the mixed technical signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages (SMA20/SMA50)
  • Decreasing volume trend
  • Bearish trend direction despite marginal MACD bullish crossover

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (22%) and healthy margins
  • Forward PE of 7.4 indicating upside relative to current price
  • Analyst upside potential of ~35% and favorable earnings outlook

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Diversified global asset‑management exposure
  • High dividend yield offset by unsustainable payout ratio
  • Elevated volatility and moderate regulatory/geographic risks

Key Metrics & Analysis

Financial Health

Revenue Growth22.00%
Profit Margin18.10%
P/E Ratio21.8
ROE13.34%
ROA5.74%
Debt/Equity41.03
P/B Ratio3.0
Industry P/E16.5

Technical Analysis

TrendBearish
RSI44.9
Support$10.72
Resistance$13.15
MA 20$11.79
MA 50$12.14
MA 200$14.00
MACDBullish
VolumeDecreasing
Fear & Greed Index93.09

Valuation

Target Price$15.57
Upside/Downside34.99%
GradeFair
TypeBlend
Dividend Yield5.34%

Risk Assessment

Beta1.16
Volatility37.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.